<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">33082323</PMID><DateCompleted><Year>2020</Year><Month>11</Month><Day>24</Day></DateCompleted><DateRevised><Year>2020</Year><Month>11</Month><Day>24</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">2041-1723</ISSN><JournalIssue CitedMedium="Internet"><Volume>11</Volume><Issue>1</Issue><PubDate><Year>2020</Year><Month>Oct</Month><Day>20</Day></PubDate></JournalIssue><Title>Nature communications</Title><ISOAbbreviation>Nat Commun</ISOAbbreviation></Journal><ArticleTitle>Selective neuronal degeneration in MATR3 S85C knock-in mouse model of early-stage ALS.</ArticleTitle><Pagination><StartPage>5304</StartPage><MedlinePgn>5304</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">5304</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.1038/s41467-020-18949-w</ELocationID><Abstract><AbstractText>A missense mutation, S85C, in the MATR3 gene is a genetic cause for amyotrophic lateral sclerosis (ALS). It is unclear how the S85C mutation affects MATR3 function and contributes to disease. Here, we develop a mouse model that harbors the S85C mutation in the endogenous Matr3 locus using the CRISPR/Cas9 system. MATR3 S85C knock-in mice recapitulate behavioral and neuropathological features of early-stage ALS including motor impairment, muscle atrophy, neuromuscular junction defects, Purkinje cell degeneration and neuroinflammation in the cerebellum and spinal cord. Our neuropathology data reveals a loss of MATR3 S85C protein in the cell bodies of Purkinje cells and motor neurons, suggesting that a decrease in functional MATR3 levels or loss of MATR3 function contributes to neuronal defects. Our findings demonstrate that the MATR3 S85C mouse model mimics aspects of early-stage ALS and would be a promising tool for future basic and preclinical research.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Kao</LastName><ForeName>Ching Serena</ForeName><Initials>CS</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>van Bruggen</LastName><ForeName>Rebekah</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Kim</LastName><ForeName>Jihye Rachel</ForeName><Initials>JR</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chen</LastName><ForeName>Xiao Xiao Lily</ForeName><Initials>XXL</Initials><Identifier Source="ORCID">0000-0003-1529-0568</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Chan</LastName><ForeName>Cadia</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0002-4810-8366</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lee</LastName><ForeName>Jooyun</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0001-6635-0669</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cho</LastName><ForeName>Woo In</ForeName><Initials>WI</Initials><Identifier Source="ORCID">0000-0001-5373-9819</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Melody</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Arndt</LastName><ForeName>Claudia</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Maksimovic</LastName><ForeName>Katarina</ForeName><Initials>K</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Khan</LastName><ForeName>Mashiat</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tan</LastName><ForeName>Qiumin</ForeName><Initials>Q</Initials><AffiliationInfo><Affiliation>Department of Cell Biology, University of Alberta, Edmonton, AB, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wilson</LastName><ForeName>Michael D</ForeName><Initials>MD</Initials><Identifier Source="ORCID">0000-0002-4015-3066</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Park</LastName><ForeName>Jeehye</ForeName><Initials>J</Initials><Identifier Source="ORCID">0000-0003-1945-6684</Identifier><AffiliationInfo><Affiliation>Genetics and Genome Biology Program, The Hospital for Sick Children, Toronto, ON, Canada. jeehye.park@sickkids.ca.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Molecular Genetics, University of Toronto, Toronto, ON, Canada. jeehye.park@sickkids.ca.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><DataBankList CompleteYN="Y"><DataBank><DataBankName>figshare</DataBankName><AccessionNumberList><AccessionNumber>10.6084/m9.figshare.12824312</AccessionNumber></AccessionNumberList></DataBank></DataBankList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType><PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>10</Month><Day>20</Day></ArticleDate></Article><MedlineJournalInfo><Country>England</Country><MedlineTA>Nat Commun</MedlineTA><NlmUniqueID>101528555</NlmUniqueID><ISSNLinking>2041-1723</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D034521">Nuclear Matrix-Associated Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D016601">RNA-Binding Proteins</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C573692">matrin-3 protein, mouse</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D004195" MajorTopicYN="N">Disease Models, Animal</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D055879" MajorTopicYN="N">Gene Knock-In Techniques</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D000073658" MajorTopicYN="N">Loss of Function Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D051379" MajorTopicYN="N">Mice</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009046" MajorTopicYN="N">Motor Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020125" MajorTopicYN="N">Mutation, Missense</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D034521" MajorTopicYN="N">Nuclear Matrix-Associated Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011689" MajorTopicYN="N">Purkinje Cells</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="N">metabolism</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D016601" MajorTopicYN="N">RNA-Binding Proteins</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName></MeshHeading></MeshHeadingList><CoiStatement>The authors declare no competing interests.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>2</Month><Day>11</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>9</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>10</Month><Day>21</Day><Hour>5</Hour><Minute>55</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>10</Month><Day>22</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2020</Year><Month>11</Month><Day>25</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">33082323</ArticleId><ArticleId IdType="pmc">PMC7576598</ArticleId><ArticleId IdType="doi">10.1038/s41467-020-18949-w</ArticleId><ArticleId IdType="pii">10.1038/s41467-020-18949-w</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Saxena S, Caroni P. Selective neuronal vulnerability in neurodegenerative diseases: from stressor thresholds to degeneration. Neuron. 2011;71:35&#x2013;48. doi: 10.1016/j.neuron.2011.06.031.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2011.06.031</ArticleId><ArticleId IdType="pubmed">21745636</ArticleId></ArticleIdList></Reference><Reference><Citation>Fu H, Hardy J, Duff KE. Selective vulnerability in neurodegenerative diseases. Nat. Neurosci. 2018;21:1350&#x2013;1358. doi: 10.1038/s41593-018-0221-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0221-2</ArticleId><ArticleId IdType="pmc">PMC6360529</ArticleId><ArticleId IdType="pubmed">30250262</ArticleId></ArticleIdList></Reference><Reference><Citation>Rowland LP, Shneider NA. Amyotrophic lateral sclerosis. N. Engl. J. Med. 2001;344:1688&#x2013;1700. doi: 10.1056/NEJM200105313442207.</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJM200105313442207</ArticleId><ArticleId IdType="pubmed">11386269</ArticleId></ArticleIdList></Reference><Reference><Citation>Pun S, Santos AF, Saxena S, Xu L, Caroni P. Selective vulnerability and pruning of phasic motoneuron axons in motoneuron disease alleviated by CNTF. Nat. Neurosci. 2006;9:408&#x2013;419. doi: 10.1038/nn1653.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn1653</ArticleId><ArticleId IdType="pubmed">16474388</ArticleId></ArticleIdList></Reference><Reference><Citation>Fischer LR, et al. Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol. 2004;185:232&#x2013;240. doi: 10.1016/j.expneurol.2003.10.004.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2003.10.004</ArticleId><ArticleId IdType="pubmed">14736504</ArticleId></ArticleIdList></Reference><Reference><Citation>Dadon-Nachum M, Melamed E, Offen D. The &#x201c;dying-back&#x201d; phenomenon of motor neurons in ALS. J. Mol. Neurosci. 2011;43:470&#x2013;477. doi: 10.1007/s12031-010-9467-1.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-010-9467-1</ArticleId><ArticleId IdType="pubmed">21057983</ArticleId></ArticleIdList></Reference><Reference><Citation>Ebstein SY, Yagudayeva I, Shneider NA. Mutant TDP-43 causes early-stage dose-dependent motor neuron degeneration in a TARDBP knockin mouse model of ALS. Cell Rep. 2019;26:364&#x2013;373 e364. doi: 10.1016/j.celrep.2018.12.045.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.celrep.2018.12.045</ArticleId><ArticleId IdType="pubmed">30625319</ArticleId></ArticleIdList></Reference><Reference><Citation>Picchiarelli G, et al. FUS-mediated regulation of acetylcholine receptor transcription at neuromuscular junctions is compromised in amyotrophic lateral sclerosis. Nat. Neurosci. 2019;22:1793&#x2013;1805. doi: 10.1038/s41593-019-0498-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-019-0498-9</ArticleId><ArticleId IdType="pmc">PMC6858880</ArticleId><ArticleId IdType="pubmed">31591561</ArticleId></ArticleIdList></Reference><Reference><Citation>Guerreiro R, Bras J, Hardy J. SnapShot: genetics of ALS and FTD. Cell. 2015;160:798&#x2013;798 e791. doi: 10.1016/j.cell.2015.01.052.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.01.052</ArticleId><ArticleId IdType="pubmed">25679767</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Chalabi A, van den Berg LH, Veldink J. Gene discovery in amyotrophic lateral sclerosis: implications for clinical management. Nat. Rev. Neurol. 2017;13:96&#x2013;104. doi: 10.1038/nrneurol.2016.182.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrneurol.2016.182</ArticleId><ArticleId IdType="pubmed">27982040</ArticleId></ArticleIdList></Reference><Reference><Citation>Gurney ME, et al. Motor neuron degeneration in mice that express a human Cu,Zn superoxide dismutase mutation. Science. 1994;264:1772&#x2013;1775. doi: 10.1126/science.8209258.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.8209258</ArticleId><ArticleId IdType="pubmed">8209258</ArticleId></ArticleIdList></Reference><Reference><Citation>Tu PH, et al. Transgenic mice carrying a human mutant superoxide dismutase transgene develop neuronal cytoskeletal pathology resembling human amyotrophic lateral sclerosis lesions. Proc. Natl Acad. Sci. USA. 1996;93:3155&#x2013;3160. doi: 10.1073/pnas.93.7.3155.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.93.7.3155</ArticleId><ArticleId IdType="pmc">PMC39778</ArticleId><ArticleId IdType="pubmed">8610185</ArticleId></ArticleIdList></Reference><Reference><Citation>De Giorgio, F., Maduro, C., Fisher, E. M. C. &amp; Acevedo-Arozena, A. Transgenic and physiological mouse models give insights into different aspects of amyotrophic lateral sclerosis. Dis. Model Mech. 12, dmm037424 (2019).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6361152</ArticleId><ArticleId IdType="pubmed">30626575</ArticleId></ArticleIdList></Reference><Reference><Citation>Wils H, et al. TDP-43 transgenic mice develop spastic paralysis and neuronal inclusions characteristic of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA. 2010;107:3858&#x2013;3863. doi: 10.1073/pnas.0912417107.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0912417107</ArticleId><ArticleId IdType="pmc">PMC2840518</ArticleId><ArticleId IdType="pubmed">20133711</ArticleId></ArticleIdList></Reference><Reference><Citation>Wegorzewska I, Bell S, Cairns NJ, Miller TM, Baloh RH. TDP-43 mutant transgenic mice develop features of ALS and frontotemporal lobar degeneration. Proc. Natl Acad. Sci. USA. 2009;106:18809&#x2013;18814. doi: 10.1073/pnas.0908767106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0908767106</ArticleId><ArticleId IdType="pmc">PMC2762420</ArticleId><ArticleId IdType="pubmed">19833869</ArticleId></ArticleIdList></Reference><Reference><Citation>Mitchell JC, et al. Overexpression of human wild-type FUS causes progressive motor neuron degeneration in an age- and dose-dependent fashion. Acta Neuropathol. 2013;125:273&#x2013;288. doi: 10.1007/s00401-012-1043-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1043-z</ArticleId><ArticleId IdType="pmc">PMC3549237</ArticleId><ArticleId IdType="pubmed">22961620</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao M, Kim JR, van Bruggen R, Park J. RNA-binding proteins in amyotrophic lateral sclerosis. Mol. Cell. 2018;41:818&#x2013;829.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6182225</ArticleId><ArticleId IdType="pubmed">30157547</ArticleId></ArticleIdList></Reference><Reference><Citation>Nakayasu H, Berezney R. Nuclear matrins: identification of the major nuclear matrix proteins. Proc. Natl Acad. Sci. USA. 1991;88:10312&#x2013;10316. doi: 10.1073/pnas.88.22.10312.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.88.22.10312</ArticleId><ArticleId IdType="pmc">PMC52918</ArticleId><ArticleId IdType="pubmed">1946450</ArticleId></ArticleIdList></Reference><Reference><Citation>Hibino Y, et al. Molecular properties and intracellular localization of rat liver nuclear scaffold protein P130. Biochim. Biophys. Acta. 2006;1759:195&#x2013;207. doi: 10.1016/j.bbaexp.2006.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbaexp.2006.04.010</ArticleId><ArticleId IdType="pubmed">16814881</ArticleId></ArticleIdList></Reference><Reference><Citation>Coelho MB, et al. Nuclear matrix protein Matrin3 regulates alternative splicing and forms overlapping regulatory networks with PTB. EMBO J. 2015;34:653&#x2013;668. doi: 10.15252/embj.201489852.</Citation><ArticleIdList><ArticleId IdType="doi">10.15252/embj.201489852</ArticleId><ArticleId IdType="pmc">PMC4365034</ArticleId><ArticleId IdType="pubmed">25599992</ArticleId></ArticleIdList></Reference><Reference><Citation>Uemura Y, et al. Matrin3 binds directly to intronic pyrimidine-rich sequences and controls alternative splicing. Genes Cell. 2017;22:785&#x2013;798. doi: 10.1111/gtc.12512.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/gtc.12512</ArticleId><ArticleId IdType="pubmed">28695676</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnson JO, et al. Mutations in the Matrin 3 gene cause familial amyotrophic lateral sclerosis. Nat. Neurosci. 2014;17:664&#x2013;666. doi: 10.1038/nn.3688.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nn.3688</ArticleId><ArticleId IdType="pmc">PMC4000579</ArticleId><ArticleId IdType="pubmed">24686783</ArticleId></ArticleIdList></Reference><Reference><Citation>Lin KP, et al. Mutational analysis of MATR3 in Taiwanese patients with amyotrophic lateral sclerosis. Neurobiol. Aging. 2015;36:2005 e2001&#x2013;2004. doi: 10.1016/j.neurobiolaging.2015.03.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.03.012</ArticleId><ArticleId IdType="pubmed">25771394</ArticleId></ArticleIdList></Reference><Reference><Citation>Origone P, et al. A novel Arg147Trp MATR3 missense mutation in a slowly progressive ALS Italian patient. Amyotroph. Lateral Scler. Frontotemporal Degener. 2015;16:530&#x2013;531. doi: 10.3109/21678421.2015.1058397.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1058397</ArticleId><ArticleId IdType="pubmed">26199109</ArticleId></ArticleIdList></Reference><Reference><Citation>Leblond CS, et al. Replication study of MATR3 in familial and sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2016;37:209 e217&#x2013;209 e221. doi: 10.1016/j.neurobiolaging.2015.09.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.09.013</ArticleId><ArticleId IdType="pubmed">26493020</ArticleId></ArticleIdList></Reference><Reference><Citation>Taylor JP, Brown RH, Jr., Cleveland DW. Decoding ALS: from genes to mechanism. Nature. 2016;539:197&#x2013;206. doi: 10.1038/nature20413.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature20413</ArticleId><ArticleId IdType="pmc">PMC5585017</ArticleId><ArticleId IdType="pubmed">27830784</ArticleId></ArticleIdList></Reference><Reference><Citation>Xu L, Li J, Tang L, Zhang N, Fan D. MATR3 mutation analysis in a Chinese cohort with sporadic amyotrophic lateral sclerosis. Neurobiol. Aging. 2016;38:218 e213&#x2013;218 e214. doi: 10.1016/j.neurobiolaging.2015.11.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2015.11.023</ArticleId><ArticleId IdType="pubmed">26708275</ArticleId></ArticleIdList></Reference><Reference><Citation>Marangi G, et al. Matrin 3 variants are frequent in Italian ALS patients. Neurobiol. Aging. 2017;49:218 e211&#x2013;218 e217. doi: 10.1016/j.neurobiolaging.2016.09.023.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2016.09.023</ArticleId><ArticleId IdType="pubmed">28029397</ArticleId></ArticleIdList></Reference><Reference><Citation>Senderek J, et al. Autosomal-dominant distal myopathy associated with a recurrent missense mutation in the gene encoding the nuclear matrix protein, matrin 3. Am. J. Hum. Genet. 2009;84:511&#x2013;518. doi: 10.1016/j.ajhg.2009.03.006.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ajhg.2009.03.006</ArticleId><ArticleId IdType="pmc">PMC2667977</ArticleId><ArticleId IdType="pubmed">19344878</ArticleId></ArticleIdList></Reference><Reference><Citation>Feit H, et al. Vocal cord and pharyngeal weakness with autosomal dominant distal myopathy: clinical description and gene localization to 5q31. Am. J. Hum. Genet. 1998;63:1732&#x2013;1742. doi: 10.1086/302166.</Citation><ArticleIdList><ArticleId IdType="doi">10.1086/302166</ArticleId><ArticleId IdType="pmc">PMC1377645</ArticleId><ArticleId IdType="pubmed">9837826</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller TJ, et al. Phenotype of matrin-3-related distal myopathy in 16 German patients. Ann. Neurol. 2014;76:669&#x2013;680. doi: 10.1002/ana.24255.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24255</ArticleId><ArticleId IdType="pubmed">25154462</ArticleId></ArticleIdList></Reference><Reference><Citation>Malik, A. M. et al. Matrin 3-dependent neurotoxicity is modified by nucleic acid binding and nucleocytoplasmic localization. Elife7, e35977 (2018).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC6050042</ArticleId><ArticleId IdType="pubmed">30015619</ArticleId></ArticleIdList></Reference><Reference><Citation>Moloney C, et al. Analysis of spinal and muscle pathology in transgenic mice overexpressing wild-type and ALS-linked mutant MATR3. Acta Neuropathol. Commun. 2018;6:137. doi: 10.1186/s40478-018-0631-0.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s40478-018-0631-0</ArticleId><ArticleId IdType="pmc">PMC6299607</ArticleId><ArticleId IdType="pubmed">30563574</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang, X. et al. Mutant MATR3 mouse model to explain multisystem proteinopathy. J. Pathol. 249, 182&#x2013;192 (2019).</Citation><ArticleIdList><ArticleId IdType="pubmed">31056746</ArticleId></ArticleIdList></Reference><Reference><Citation>Rayaprolu S, et al. Heterogeneity of Matrin 3 in the developing and aging murine central nervous system. J. Comp. Neurol. 2016;524:2740&#x2013;2752. doi: 10.1002/cne.23986.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cne.23986</ArticleId><ArticleId IdType="pmc">PMC5832027</ArticleId><ArticleId IdType="pubmed">26878116</ArticleId></ArticleIdList></Reference><Reference><Citation>Burrell JR, et al. The frontotemporal dementia-motor neuron disease continuum. Lancet. 2016;388:919&#x2013;931. doi: 10.1016/S0140-6736(16)00737-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(16)00737-6</ArticleId><ArticleId IdType="pubmed">26987909</ArticleId></ArticleIdList></Reference><Reference><Citation>Lasagna-Reeves CA, et al. Reduction of Nuak1 decreases tau and reverses phenotypes in a tauopathy mouse model. Neuron. 2016;92:407&#x2013;418. doi: 10.1016/j.neuron.2016.09.022.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.09.022</ArticleId><ArticleId IdType="pmc">PMC5745060</ArticleId><ArticleId IdType="pubmed">27720485</ArticleId></ArticleIdList></Reference><Reference><Citation>Shoji, H., Takao, K., Hattori, S. &amp; Miyakawa, T. Contextual and cued fear conditioning test using a video analyzing system in mice. J. Vis. Exp. 50871 (2014).</Citation><ArticleIdList><ArticleId IdType="pmc">PMC4122439</ArticleId><ArticleId IdType="pubmed">24637495</ArticleId></ArticleIdList></Reference><Reference><Citation>Mochizuki Y, et al. Familial ALS with FUS P525L mutation: two Japanese sisters with multiple systems involvement. J. Neurol. Sci. 2012;323:85&#x2013;92. doi: 10.1016/j.jns.2012.08.016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jns.2012.08.016</ArticleId><ArticleId IdType="pubmed">22980027</ArticleId></ArticleIdList></Reference><Reference><Citation>Prell T, Grosskreutz J. The involvement of the cerebellum in amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Frontotemporal Degener. 2013;14:507&#x2013;515. doi: 10.3109/21678421.2013.812661.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2013.812661</ArticleId><ArticleId IdType="pubmed">23889583</ArticleId></ArticleIdList></Reference><Reference><Citation>Koziol LF, et al. Consensus paper: the cerebellum&#x2019;s role in movement and cognition. Cerebellum. 2014;13:151&#x2013;177. doi: 10.1007/s12311-013-0511-x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12311-013-0511-x</ArticleId><ArticleId IdType="pmc">PMC4089997</ArticleId><ArticleId IdType="pubmed">23996631</ArticleId></ArticleIdList></Reference><Reference><Citation>Afshar P, et al. Overexpression of human SOD1 leads to discrete defects in the cerebellar architecture in the mouse. Front. Neuroanat. 2017;11:22. doi: 10.3389/fnana.2017.00022.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnana.2017.00022</ArticleId><ArticleId IdType="pmc">PMC5372795</ArticleId><ArticleId IdType="pubmed">28424594</ArticleId></ArticleIdList></Reference><Reference><Citation>Lalancette-Hebert M, Sharma A, Lyashchenko AK, Shneider NA. Gamma motor neurons survive and exacerbate alpha motor neuron degeneration in ALS. Proc. Natl Acad. Sci. USA. 2016;113:E8316&#x2013;E8325. doi: 10.1073/pnas.1605210113.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.1605210113</ArticleId><ArticleId IdType="pmc">PMC5187676</ArticleId><ArticleId IdType="pubmed">27930290</ArticleId></ArticleIdList></Reference><Reference><Citation>Friese A, et al. Gamma and alpha motor neurons distinguished by expression of transcription factor Err3. Proc. Natl Acad. Sci. USA. 2009;106:13588&#x2013;13593. doi: 10.1073/pnas.0906809106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.0906809106</ArticleId><ArticleId IdType="pmc">PMC2716387</ArticleId><ArticleId IdType="pubmed">19651609</ArticleId></ArticleIdList></Reference><Reference><Citation>Frey D, et al. Early and selective loss of neuromuscular synapse subtypes with low sprouting competence in motoneuron diseases. J. Neurosci. 2000;20:2534&#x2013;2542. doi: 10.1523/JNEUROSCI.20-07-02534.2000.</Citation><ArticleIdList><ArticleId IdType="doi">10.1523/JNEUROSCI.20-07-02534.2000</ArticleId><ArticleId IdType="pmc">PMC6772256</ArticleId><ArticleId IdType="pubmed">10729333</ArticleId></ArticleIdList></Reference><Reference><Citation>Mensch A, et al. The p.S85C-mutation in MATR3 impairs stress granule formation in Matrin-3 myopathy. Exp. Neurol. 2018;306:222&#x2013;231. doi: 10.1016/j.expneurol.2018.05.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.expneurol.2018.05.012</ArticleId><ArticleId IdType="pubmed">29763601</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao, C. S. et al. E-MTAB-8838 - Gene expression changes in the cerebellum, cortex and spinal cord of MATR3 S85C knock-in mice at pre-symptomatic stage 8-10 weeks of age. ArrayExpresshttps://identifiers.org/arrayexpress:E-MTAB-8838 (2020).</Citation></Reference><Reference><Citation>Pang SS, et al. The cryo-EM structure of the acid activatable pore-forming immune effector macrophage-expressed gene 1. Nat. Commun. 2019;10:4288. doi: 10.1038/s41467-019-12279-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-12279-2</ArticleId><ArticleId IdType="pmc">PMC6753088</ArticleId><ArticleId IdType="pubmed">31537793</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalia N, Kaur M, Sharma S, Singh J. A comprehensive in silico analysis of regulatory SNPs of human CLEC7A gene and its validation as genotypic and phenotypic disease marker in recurrent vulvovaginal infections. Front Cell Infect. Microbiol. 2018;8:65. doi: 10.3389/fcimb.2018.00065.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fcimb.2018.00065</ArticleId><ArticleId IdType="pmc">PMC5869923</ArticleId><ArticleId IdType="pubmed">29616193</ArticleId></ArticleIdList></Reference><Reference><Citation>Gallego-Iradi MC, et al. Subcellular localization of Matrin 3 containing mutations associated with ALS and distal myopathy. PLoS ONE. 2015;10:e0142144. doi: 10.1371/journal.pone.0142144.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0142144</ArticleId><ArticleId IdType="pmc">PMC4631352</ArticleId><ArticleId IdType="pubmed">26528920</ArticleId></ArticleIdList></Reference><Reference><Citation>Boehringer A, et al. ALS associated mutations in Matrin 3 alter protein-protein interactions and impede mRNA nuclear export. Sci. Rep. 2017;7:14529. doi: 10.1038/s41598-017-14924-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-017-14924-6</ArticleId><ArticleId IdType="pmc">PMC5674072</ArticleId><ArticleId IdType="pubmed">29109432</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao, M. et al. Knockdown of genes involved in axonal transport enhances the toxicity of human neuromuscular disease-linked MATR3 mutations in Drosophila. FEBS Lett. 10.1002/1873-3468.13858 (2020).</Citation><ArticleIdList><ArticleId IdType="pubmed">32515490</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobrowolny G, et al. Skeletal muscle is a primary target of SOD1G93A-mediated toxicity. Cell Metab. 2008;8:425&#x2013;436. doi: 10.1016/j.cmet.2008.09.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmet.2008.09.002</ArticleId><ArticleId IdType="pubmed">19046573</ArticleId></ArticleIdList></Reference><Reference><Citation>Wong M, Martin LJ. Skeletal muscle-restricted expression of human SOD1 causes motor neuron degeneration in transgenic mice. Hum. Mol. Genet. 2010;19:2284&#x2013;2302. doi: 10.1093/hmg/ddq106.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/hmg/ddq106</ArticleId><ArticleId IdType="pmc">PMC2865380</ArticleId><ArticleId IdType="pubmed">20223753</ArticleId></ArticleIdList></Reference><Reference><Citation>Corcia P, et al. Pure cerebellar ataxia linked to large C9orf72 repeat expansion. Amyotroph. Lateral Scler. Frontotemporal Degener. 2016;17:301&#x2013;303. doi: 10.3109/21678421.2015.1113298.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2015.1113298</ArticleId><ArticleId IdType="pubmed">26609732</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan RH, et al. Cerebellar neuronal loss in amyotrophic lateral sclerosis cases with ATXN2 intermediate repeat expansions. Ann. Neurol. 2016;79:295&#x2013;305. doi: 10.1002/ana.24565.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.24565</ArticleId><ArticleId IdType="pubmed">26599997</ArticleId></ArticleIdList></Reference><Reference><Citation>Aguiar J, et al. Ubiquitous expression of human SCA2 gene under the regulation of the SCA2 self promoter cause specific Purkinje cell degeneration in transgenic mice. Neurosci. Lett. 2006;392:202&#x2013;206. doi: 10.1016/j.neulet.2005.09.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neulet.2005.09.020</ArticleId><ArticleId IdType="pubmed">16203087</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Y, et al. C9orf72 BAC mouse model with motor deficits and neurodegenerative features of ALS/FTD. Neuron. 2016;90:521&#x2013;534. doi: 10.1016/j.neuron.2016.04.005.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2016.04.005</ArticleId><ArticleId IdType="pubmed">27112499</ArticleId></ArticleIdList></Reference><Reference><Citation>Duan W, et al. Deletion of Tbk1 disrupts autophagy and reproduces behavioral and locomotor symptoms of FTD-ALS in mice. Aging. 2019;11:2457&#x2013;2476. doi: 10.18632/aging.101936.</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.101936</ArticleId><ArticleId IdType="pmc">PMC6519994</ArticleId><ArticleId IdType="pubmed">31039129</ArticleId></ArticleIdList></Reference><Reference><Citation>Hao Z, et al. Motor dysfunction and neurodegeneration in a C9orf72 mouse line expressing poly-PR. Nat. Commun. 2019;10:2906. doi: 10.1038/s41467-019-10956-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-019-10956-w</ArticleId><ArticleId IdType="pmc">PMC6606620</ArticleId><ArticleId IdType="pubmed">31266945</ArticleId></ArticleIdList></Reference><Reference><Citation>Arai T, et al. TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Biochem. Biophys. Res. Commun. 2006;351:602&#x2013;611. doi: 10.1016/j.bbrc.2006.10.093.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbrc.2006.10.093</ArticleId><ArticleId IdType="pubmed">17084815</ArticleId></ArticleIdList></Reference><Reference><Citation>Neumann M, et al. Ubiquitinated TDP-43 in frontotemporal lobar degeneration and amyotrophic lateral sclerosis. Science. 2006;314:130&#x2013;133. doi: 10.1126/science.1134108.</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.1134108</ArticleId><ArticleId IdType="pubmed">17023659</ArticleId></ArticleIdList></Reference><Reference><Citation>Pikkarainen M, Hartikainen P, Alafuzoff I. Neuropathologic features of frontotemporal lobar degeneration with ubiquitin-positive inclusions visualized with ubiquitin-binding protein p62 immunohistochemistry. J. Neuropathol. Exp. Neurol. 2008;67:280&#x2013;298. doi: 10.1097/NEN.0b013e31816a1da2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NEN.0b013e31816a1da2</ArticleId><ArticleId IdType="pubmed">18379439</ArticleId></ArticleIdList></Reference><Reference><Citation>Geser F, et al. Clinical and pathological continuum of multisystem TDP-43 proteinopathies. Arch. Neurol. 2009;66:180&#x2013;189. doi: 10.1001/archneurol.2008.558.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2008.558</ArticleId><ArticleId IdType="pmc">PMC2774117</ArticleId><ArticleId IdType="pubmed">19204154</ArticleId></ArticleIdList></Reference><Reference><Citation>Seppanen A, et al. Expression of collagen XVII and ubiquitin-binding protein p62 in motor neuron disease. Brain Res. 2009;1247:171&#x2013;177. doi: 10.1016/j.brainres.2008.10.020.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2008.10.020</ArticleId><ArticleId IdType="pubmed">18992722</ArticleId></ArticleIdList></Reference><Reference><Citation>King A, Maekawa S, Bodi I, Troakes C, Al-Sarraj S. Ubiquitinated, p62 immunopositive cerebellar cortical neuronal inclusions are evident across the spectrum of TDP-43 proteinopathies but are only rarely additionally immunopositive for phosphorylation-dependent TDP-43. Neuropathology. 2011;31:239&#x2013;249. doi: 10.1111/j.1440-1789.2010.01171.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1440-1789.2010.01171.x</ArticleId><ArticleId IdType="pubmed">21118398</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Sarraj S, et al. p62 positive, TDP-43 negative, neuronal cytoplasmic and intranuclear inclusions in the cerebellum and hippocampus define the pathology of C9orf72-linked FTLD and MND/ALS. Acta Neuropathol. 2011;122:691&#x2013;702. doi: 10.1007/s00401-011-0911-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-011-0911-2</ArticleId><ArticleId IdType="pubmed">22101323</ArticleId></ArticleIdList></Reference><Reference><Citation>Kassubek J, et al. Global brain atrophy and corticospinal tract alterations in ALS, as investigated by voxel-based morphometry of 3-D MRI. Amyotroph. Lateral Scler. Other Mot. Neuron Disord. 2005;6:213&#x2013;220. doi: 10.1080/14660820510038538.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/14660820510038538</ArticleId><ArticleId IdType="pubmed">16319024</ArticleId></ArticleIdList></Reference><Reference><Citation>Thivard L, et al. Diffusion tensor imaging and voxel based morphometry study in amyotrophic lateral sclerosis: relationships with motor disability. J. Neurol. Neurosurg. Psychiatry. 2007;78:889&#x2013;892. doi: 10.1136/jnnp.2006.101758.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp.2006.101758</ArticleId><ArticleId IdType="pmc">PMC2117724</ArticleId><ArticleId IdType="pubmed">17635981</ArticleId></ArticleIdList></Reference><Reference><Citation>Gellersen HM, et al. Cerebellar atrophy in neurodegeneration-a meta-analysis. J. Neurol. Neurosurg. Psychiatry. 2017;88:780&#x2013;788. doi: 10.1136/jnnp-2017-315607.</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jnnp-2017-315607</ArticleId><ArticleId IdType="pubmed">28501823</ArticleId></ArticleIdList></Reference><Reference><Citation>Lallemand-Breitenbach V, de The H. PML nuclear bodies. Cold Spring Harb. Perspect. Biol. 2010;2:a000661. doi: 10.1101/cshperspect.a000661.</Citation><ArticleIdList><ArticleId IdType="doi">10.1101/cshperspect.a000661</ArticleId><ArticleId IdType="pmc">PMC2857171</ArticleId><ArticleId IdType="pubmed">20452955</ArticleId></ArticleIdList></Reference><Reference><Citation>Giordano G, et al. Activation of NMDA receptors induces protein kinase A-mediated phosphorylation and degradation of matrin 3. Blocking these effects prevents NMDA-induced neuronal death. J. Neurochem. 2005;94:808&#x2013;818. doi: 10.1111/j.1471-4159.2005.03235.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1471-4159.2005.03235.x</ArticleId><ArticleId IdType="pubmed">16000164</ArticleId></ArticleIdList></Reference><Reference><Citation>White MA, et al. TDP-43 gains function due to perturbed autoregulation in a Tardbp knock-in mouse model of ALS-FTD. Nat. Neurosci. 2018;21:552&#x2013;563. doi: 10.1038/s41593-018-0113-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41593-018-0113-5</ArticleId><ArticleId IdType="pmc">PMC5884423</ArticleId><ArticleId IdType="pubmed">29556029</ArticleId></ArticleIdList></Reference><Reference><Citation>Park J, et al. RAS-MAPK-MSK1 pathway modulates ataxin 1 protein levels and toxicity in SCA1. Nature. 2013;498:325&#x2013;331. doi: 10.1038/nature12204.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nature12204</ArticleId><ArticleId IdType="pmc">PMC4020154</ArticleId><ArticleId IdType="pubmed">23719381</ArticleId></ArticleIdList></Reference><Reference><Citation>Tan Q, et al. Extensive cryptic splicing upon loss of RBM17 and TDP43 in neurodegeneration models. Hum. Mol. Genet. 2016;25:5083&#x2013;5093.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC5968355</ArticleId><ArticleId IdType="pubmed">28007900</ArticleId></ArticleIdList></Reference><Reference><Citation>Bolger AM, Lohse M, Usadel B. Trimmomatic: a flexible trimmer for Illumina sequence data. Bioinformatics. 2014;30:2114&#x2013;2120. doi: 10.1093/bioinformatics/btu170.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btu170</ArticleId><ArticleId IdType="pmc">PMC4103590</ArticleId><ArticleId IdType="pubmed">24695404</ArticleId></ArticleIdList></Reference><Reference><Citation>Dobin A, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15&#x2013;21. doi: 10.1093/bioinformatics/bts635.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts635</ArticleId><ArticleId IdType="pmc">PMC3530905</ArticleId><ArticleId IdType="pubmed">23104886</ArticleId></ArticleIdList></Reference><Reference><Citation>Garcia-Alcalde F, et al. Qualimap: evaluating next-generation sequencing alignment data. Bioinformatics. 2012;28:2678&#x2013;2679. doi: 10.1093/bioinformatics/bts503.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/bts503</ArticleId><ArticleId IdType="pubmed">22914218</ArticleId></ArticleIdList></Reference><Reference><Citation>Liao Y, Smyth GK, Shi W. featureCounts: an efficient general purpose program for assigning sequence reads to genomic features. Bioinformatics. 2014;30:923&#x2013;930. doi: 10.1093/bioinformatics/btt656.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btt656</ArticleId><ArticleId IdType="pubmed">24227677</ArticleId></ArticleIdList></Reference><Reference><Citation>McCarthy DJ, Chen Y, Smyth GK. Differential expression analysis of multifactor RNA-Seq experiments with respect to biological variation. Nucleic Acids Res. 2012;40:4288&#x2013;4297. doi: 10.1093/nar/gks042.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gks042</ArticleId><ArticleId IdType="pmc">PMC3378882</ArticleId><ArticleId IdType="pubmed">22287627</ArticleId></ArticleIdList></Reference><Reference><Citation>Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139&#x2013;140. doi: 10.1093/bioinformatics/btp616.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btp616</ArticleId><ArticleId IdType="pmc">PMC2796818</ArticleId><ArticleId IdType="pubmed">19910308</ArticleId></ArticleIdList></Reference><Reference><Citation>Raudvere U, et al. g:Profiler: a web server for functional enrichment analysis and conversions of gene lists (2019 update) Nucleic Acids Res. 2019;47:W191&#x2013;W198. doi: 10.1093/nar/gkz369.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/nar/gkz369</ArticleId><ArticleId IdType="pmc">PMC6602461</ArticleId><ArticleId IdType="pubmed">31066453</ArticleId></ArticleIdList></Reference><Reference><Citation>Kao, C. S. et al. Raw immunofluorescence and immunohistochemistry images of MATR3 S85C knock-in mice. 10.6084/m9.figshare.12824312 (2020).</Citation></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>